Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

CD8 T cell defect of TNF-α and IL-2 in DNAM-1 deficient mice delays clearance in vivo of a persistent virus infection.

Welch MJ, Teijaro JR, Lewicki HA, Colonna M, Oldstone MB.

Virology. 2012 Aug 1;429(2):163-70. doi: 10.1016/j.virol.2012.04.006. Epub 2012 May 12.

2.

Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest.

Popkin DL, Teijaro JR, Lee AM, Lewicki H, Emonet S, de la Torre JC, Oldstone M.

J Virol. 2011 Aug;85(15):7928-32. doi: 10.1128/JVI.00486-11. Epub 2011 May 25.

3.

RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.

Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MB.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):331-6. doi: 10.1073/pnas.1017241108. Epub 2010 Dec 20.

4.

Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.

Homann D, Lewicki H, Brooks D, Eberlein J, Mallet-Designé V, Teyton L, Oldstone MB.

Virology. 2007 Jun 20;363(1):113-23. Epub 2007 Feb 21.

5.

Mass spectrometry reveals specific and global molecular transformations during viral infection.

Go EP, Wikoff WR, Shen Z, O'Maille G, Morita H, Conrads TP, Nordstrom A, Trauger SA, Uritboonthai W, Lucas DA, Chan KC, Veenstra TD, Lewicki H, Oldstone MB, Schneemann A, Siuzdak G.

J Proteome Res. 2006 Sep;5(9):2405-16.

6.
7.

A role for dual viral hits in causation of subacute sclerosing panencephalitis.

Oldstone MB, Dales S, Tishon A, Lewicki H, Martin L.

J Exp Med. 2005 Nov 7;202(9):1185-90. Epub 2005 Oct 31.

8.

T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies.

Lewicki H, Tishon A, Homann D, Mazarguil H, Laval F, Asensio VC, Campbell IL, DeArmond S, Coon B, Teng C, Gairin JE, Oldstone MB.

J Virol. 2003 Mar;77(6):3799-808.

9.

One, two, or three step: measles virus receptor dance.

Oldstone MB, Homann D, Lewicki H, Stevenson D.

Virology. 2002 Aug 1;299(2):162-3. Review. No abstract available.

10.

Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement in neuroinvasion.

Oldstone MB, Race R, Thomas D, Lewicki H, Homann D, Smelt S, Holz A, Koni P, Lo D, Chesebro B, Flavell R.

J Virol. 2002 May;76(9):4357-63.

11.

Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Patterson JB, Cornu TI, Redwine J, Dales S, Lewicki H, Holz A, Thomas D, Billeter MA, Oldstone MB.

Virology. 2001 Dec 20;291(2):215-25.

12.

Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.

Oldstone MB, Lewicki H, Homann D, Nguyen C, Julien S, Gairin JE.

J Virol. 2001 Jul;75(14):6273-8.

13.
14.
15.

Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells.

Sevilla N, Kunz S, Holz A, Lewicki H, Homann D, Yamada H, Campbell KP, de La Torre JC, Oldstone MB.

J Exp Med. 2000 Nov 6;192(9):1249-60.

16.
17.

V and C proteins of measles virus function as virulence factors in vivo.

Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB.

Virology. 2000 Feb 1;267(1):80-9.

18.

Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease.

Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A.

Cell. 1999 Sep 3;98(5):629-40.

19.
20.

In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.

von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.

J Immunol. 1998 Nov 1;161(9):5087-96.

21.

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, Shaw GM.

Nat Med. 1997 Feb;3(2):205-11.

PMID:
9018240
22.
24.

An essential role for type 1 interferon-gamma in terminating persistent viral infection.

Tishon A, Lewicki H, Rall G, Von Herrath M, Oldstone MB.

Virology. 1995 Sep 10;212(1):244-50.

25.

CTL escape viral variants. II. Biologic activity in vivo.

Lewicki HA, Von Herrath MG, Evans CF, Whitton JL, Oldstone MB.

Virology. 1995 Aug 20;211(2):443-50.

26.

CTL escape viral variants. I. Generation and molecular characterization.

Lewicki H, Tishon A, Borrow P, Evans CF, Gairin JE, Hahn KM, Jewell DA, Wilson IA, Oldstone MB.

Virology. 1995 Jun 20;210(1):29-40.

27.
28.

Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells.

Hahn K, DeBiasio R, Tishon A, Lewicki H, Gairin JE, LaRocca G, Taylor DL, Oldstone M.

Virology. 1994 Jun;201(2):330-40.

PMID:
8184542
29.

Novel LCMV-specific H-2k restricted CTL clones recognize internal viral gene products and cause CNS disease.

Lewicki H, McKee TA, Tishon A, Salvato M, Whitton JL, Oldstone MB.

J Neuroimmunol. 1992 Nov;41(1):15-20.

PMID:
1281166
30.

A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination.

Oldstone MB, Tishon A, Geckeler R, Lewicki H, Whitton JL.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2752-5.

32.

Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.

Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H.

Cell. 1991 Apr 19;65(2):319-31.

PMID:
1901765
34.

Cytotoxic T lymphocytes do not control lymphocytic choriomeningitis virus infection of BB diabetes-prone rats.

Oldstone MB, Tishon A, Schwimmbeck PL, Shyp S, Lewicki H, Dyrberg T.

J Gen Virol. 1990 Apr;71 ( Pt 4):785-91.

PMID:
2324708
35.

Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity.

Whitton JL, Tishon A, Lewicki H, Gebhard J, Cook T, Salvato M, Joly E, Oldstone MB.

J Virol. 1989 Oct;63(10):4303-10.

38.

Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.

Whitton JL, Gebhard JR, Lewicki H, Tishon A, Oldstone MB.

J Virol. 1988 Mar;62(3):687-95.

39.

Differential effects of MHV-4 infection of astrocytes and oligodendrocytes in vitro.

Knobler RL, Cole R, de Vellis J, Lewicki H, Buchmeier MJ, Oldstone MB.

Adv Exp Med Biol. 1987;218:231-7. No abstract available.

PMID:
2829532
40.

Properties and characterization of monoclonal antibodies to Tacaribe virus.

Howard CR, Lewicki H, Allison L, Salter M, Buchmeier MJ.

J Gen Virol. 1985 Jul;66 ( Pt 7):1383-95.

PMID:
2410550
41.

Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL.

Virology. 1984 Jan 30;132(2):261-70.

PMID:
6199889
42.

Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB.

Virology. 1981 Aug;113(1):73-85. No abstract available.

PMID:
6267791
43.

Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses.

Buchmeier MJ, Lewicki HA, Tomori O, Johnson KM.

Nature. 1980 Dec 4;288(5790):486-7.

PMID:
6160402
44.

[Nurses' cooperation in hospital planning and construction].

Lewicki HB.

Dtsch Zentralbl Krankenpfl. 1966 May;10(5):203-8. German. No abstract available.

PMID:
5176800
45.

[Hospitals of skyscraper construction].

LEWICKI HB.

Sven Lakartidn. 1956 Aug 17;53(33):2082-92. Swedish. No abstract available.

PMID:
13360695

Supplemental Content

Loading ...
Support Center